LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea December 2, 2025 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team. “Lucile is an accomplished healthcare executive with more than 25 [...]
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer December 2, 2025 Swan EndoSurgical, an emerging leader in flexible endoluminal surgical robotics, today announced the appointment of Erik Todd as its Chief Executive Officer. Erik joins Swan following more than 25 years of leadership at Stryker Corporation, where he most recently served as Vice President and General Manager of the Robotics and Enabling Technologies division. This press [...]
Unifyr Appoints Michael Kugler as CEO to Accelerate Global Scale, Enterprise Expansion, and AI-Driven Innovation December 2, 2025 Unifyr, the global leader in enterprise Partner Relationship Management (PRM), today announced the appointment of Michael Kugler as Chief Executive Officer (CEO). David Winkens assumes the role of Chief Operating Officer (COO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202784758/en/ Kugler joins Unifyr following a number of successful management positions with a [...]
Epassi Announces Leadership Transition November 26, 2025 Nickyl Raithatha to join as Group CEO Pekka Rantala to remain on Board as Non-Executive Chair
Everest Announces Chief Financial Officer Transition November 20, 2025 Elias Habayeb Appointed Executive Vice President and Group Chief Financial Officer, Succeeding Mark Kociancic
Ex-Microsoft Privacy Head Julie Brill and MIT’s Daniel Weitzner Join Ethyca Board to Advance Context-Aware Data Infrastructure for AI November 20, 2025 Ethyca, the enterprise software company building context-aware data infrastructure for the AI era, today announced the appointment of Julie Brill, Expert-in-Residence at Harvard, former Chief Privacy Officer at Microsoft, and former Commissioner of the U.S. Federal Trade Commission, and Daniel Weitzner, Director of MIT’s Internet Policy Research Initiative and former U.S. Deputy Chief Technology Officer, [...]
Gary Haase to Join Everest as EVP, CEO of Legacy Operations November 17, 2025 Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, today announced the appointment of Gary Haase as Executive Vice President and CEO of Legacy Operations, effective December 1, 2025. He will report to Jim Williamson, Everest’s President and CEO, and will join the Company’s Executive Leadership Team. The [...]
Dilawer Farazi Returns to Loomis Sayles as Co-Head and Portfolio Manager on the Emerging Markets Debt Team November 17, 2025 Loomis, Sayles & Company is pleased to announce that Dilawer Farazi, ACA, has rejoined the firm as Co-Head and Portfolio Manager of the Emerging Markets Debt (EMD) Team. Dilawer becomes the firm’s first London-based portfolio manager. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117681347/en/ Dilawer brings over two decades of experience in [...]
Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor November 17, 2025 Mike Kachmer to retire following a distinguished 43-year career, including nearly 12 years as Chairman & CEO of Duravant Jill Evanko to succeed Mr. Kachmer as Duravant’s Chief Executive Officer
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization November 17, 2025 Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the commercialization of its INDUCE-seq® platform, now available to cell and gene therapy developers worldwide. To drive the company’s commercial expansion, Terry Pizzie has been appointed as CEO, bringing extensive experience from leading and [...]